US and Europe Pharma and Biotech Cro Market is anticipated to register a healthy market expansion at a CAGR of 10.32% during the review period.
CROs (Contract Research Organizations) play an important role in the pharmaceutical and biotechnology industries by providing outsourced services such as drug development, clinical trials, regulatory affairs, and more. These include drug development, clinical trials, regulatory affairs, and post-market surveillance. CROs help streamline the drug development process by managing various aspects of clinical trials, from design and protocol development to patient recruitment, data collection, and analysis.
The increasing research and development investments by pharmaceutical and biotechnology industries, adoption of cutting-edge technology such as artificial intelligence, big data analytics, and precision medicine, and increased number of clinical trials and studies generates demand for CRO services for trial management and support are the major factors driving the growth of the US & Europe pharma and biotech CRO market. However, the intense competition among CROs and data privacy and security concerns are expected to hamper the growth of the global market. Nevertheless, emerging markets offer significant growth opportunities, and the growing investment in personalized and precision medicine is anticipated to create lucrative opportunities for the market.
Market Segmentation
Based on Service Type, the US and Europe Pharma and Biotech CRO Market has been segmented into clinical development services, formulation development services, pharmacovigilance services, laboratory services, consulting services, data management services, and others includes regulatory affairs services and others.
Based on phase, the Market has been segmented into Phase I, Phase II, Phase III, Phase IV. and Post Marketing Studies (PMS).
Based on Indication, the Market has been segmented into cardiovascular, oncology, dermatology, gynecology, neurology, respiratory diseases, orthopedics, ophthalmology and others includes.
Based on end user, the US and Europe Pharma and Biotech CRO Market has been segmented into pharmaceutical companies, and biopharmaceutical companies.
Based on region/country, the Market has been segmented into US, and Europe.
Major Players
The key market players include KLIF, Ergomed Group, Astrum CRO, Ergomed Group, Optimapharm, FGK Clinical Research, Kapadi, TFS HealthScience, Winicker Norimed GmbH, JSB Solutions Srl, and IQVIA Holding, Inc.
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 3 Research Methodology
- 3.1 Overview
- 3.2 Data Flow
- 3.2.1 Data Mining Process
- 3.3 Purchased Database:
- 3.4 Secondary Sources:
- 3.4.1 Secondary Research Data Flow:
- 3.5 Primary Research:
- 3.5.1 Primary Research Data Flow:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.6 Approaches For Market Size Estimation:
- 3.6.1 Revenue Analysis Approach
- 3.7 Data Forecasting
- 3.7.1 Data Forecasting Type
- 3.8 Data Modeling
- 3.8.1 Microeconomic Factor Analysis:
- 3.8.2 Data Modeling:
- 3.9 Teams And Analyst Contribution
- 4 Market Dynamics
- 4.1 Introduction
- 4.2 Drivers
- 4.2.1 Increasing Research And Development Investments By Pharmaceutical And Biotechnology Industries
- 4.2.2 Growing Adoption Of Cutting-edge Technology Such As Artificial Intelligence, Big Data Analytics, And Precision Medicine
- 4.2.3 Increased Number Of Clinical Trials And Studies Generates Demand For Cro Services For Trial Management And Support
- 4.3 Restraints
- 4.3.1 High Cost Of Photodynamic Therapy Equipment And Procedures
- 4.4 Opportunity
- 4.4.1 Growing Investment In Personalized And Precision Medicine
- 5 Market Factor Analysis
- 5.1 Porter's Five Forces Model
- 5.1.1 Threat Of New Entrants
- 5.1.2 Bargaining Power Of Suppliers
- 5.1.3 Threat Of Substitutes
- 5.1.4 Bargaining Power Of Buyers
- 5.1.5 Intensity Of Rivalry
- 5.2 Impact Of Covid-19 On The Us & Europe Pharma And Biotech Cro Market
- 5.3 List Of Contract Research Organization By Europe/Europe Countries Offering Services To Pharmaceutical And Biopharmaceutical
- 6 Us And Europe Pharma And Biotech Cro Market, By Service Type
- 6.1 Overview
- 6.2 Clinical Development Services
- 6.3 Formulation Development Services
- 6.4 Pharmacovigilance Services
- 6.5 Laboratory Services
- 6.6 Consulting Services
- 6.7 Data Management Services
- 6.8 Others
- 7 Us And Europe Pharma And Biotech Cro Market, By Phase
- 7.1 Overview
- 7.2 Phase I
- 7.3 Phase Ii
- 7.4 Phase Iii
- 7.5 Phase Iv
- 7.6 Post Marketing Studies (Pms)
- 8 Us And Europe Pharma And Biotech Cro Market, By Indication
- 8.1 Overview
- 8.2 Cardiovascular
- 8.3 Oncology
- 8.4 Dermatology
- 8.5 Gynaecology
- 8.6 Neurology
- 8.7 Respiratory Diseases
- 8.8 Orthopaedics
- 8.9 Ophthalmology
- 8.10 Others
- 9 Us And Europe Pharma And Biotech Cro Market, By End User
- 9.1 Overview
- 9.2 Pharmaceutical Companies
- 9.3 Biopharmaceutical Companies
- 10 Us & Europe Pharma And Biotech Cro Market, By Region
- 10.1 Overview
- 10.2 Us
- 10.3 Europe
- 10.4 Eastern Europe
- 10.4.1 Poland
- 10.4.2 Romania
- 10.4.3 Bulgaria
- 10.4.4 Belarus
- 10.4.5 Georgia
- 10.4.6 Latvia
- 10.4.7 Lithuania
- 10.4.8 Rest Of Eastern Europe
- 10.5 Western Europe
- 10.5.1 Germany
- 10.5.2 France
- 10.5.3 Uk
- 10.5.4 Spain
- 10.5.5 Switzerland
- 10.5.6 Netherlands
- 10.5.7 Rest Of Western Europe
- 10.6 Northern Europe
- 10.6.1 Denmark
- 10.6.2 Sweden
- 10.6.3 Norway
- 10.6.4 Iceland
- 10.6.5 Finland
- 10.6.6 Ireland
- 10.6.7 Rest Of Northern Europe
- 10.7 Southern Europe
- 10.7.1 Greece
- 10.7.2 Portugal
- 10.7.3 Croatia
- 10.7.4 Rest Of Southern Europe
- 10.8 Central Europe
- 10.8.1 Hungary
- 10.8.2 Slovakia
- 10.8.3 Czech Republic
- 10.8.4 Austria
- 10.8.5 Rest Of Central Europe
- 11 Competitive Landscape
- 11.1 Introduction
- 11.2 Market Share Analysis, 2023
- 11.3 Competitor Dashboard
- 11.4 Public Players Stock Summary
- 11.5 Comparative Analysis: Key Players Finanical
- 11.6 Key Developments & Growth Strategies
- 11.6.1 Aquisition
- 11.6.2 Facility Launch
- 11.6.3 Investment
- 11.6.4 Expansion
- 12 Company Profiles
- 12.1 Klifo
- 12.1.1 Company Overview
- 12.1.2 Financial Overview
- 12.1.3 Service Offered
- 12.1.4 Key Developments
- 12.1.5 Key Strategies
- 12.2 Optimapharm
- 12.2.1 Company Overview
- 12.2.2 Financial Overview
- 12.2.3 Services Offered
- 12.2.4 Key Developments
- 12.2.5 Swot Analysis
- 12.2.6 Key Strategies
- 12.3 Fgk Clinical Research Gmbh
- 12.3.1 Company Overview
- 12.3.2 Financial Overview
- 12.3.3 Service Offered
- 12.3.4 Key Developments
- 12.3.5 Key Strategies
- 12.4 Ergomed Group
- 12.4.1 Company Overview
- 12.4.2 Financial Overview
- 12.4.3 Service Offered
- 12.4.4 Key Developments
- 12.4.5 Swot Analysis
- 12.4.6 Key Strategies
- 12.5 Astrum/ Pharmalog
- 12.5.1 Company Overview
- 12.5.2 Financial Overview
- 12.5.3 Service Offered
- 12.5.4 Key Developments
- 12.5.5 Key Strategies
- 12.6 Kapadi
- 12.6.1 Company Overview
- 12.6.2 Financial Overview
- 12.6.3 Services Offered
- 12.6.4 Key Developments
- 12.6.5 Swot Analysis
- 12.6.6 Key Strategies
- 12.7 Tfs Healthscience
- 12.7.1 Company Overview
- 12.7.2 Financial Overview
- 12.7.3 Services Offered
- 12.7.4 Key Developments
- 12.7.5 Key Strategies
- 12.8 Winicker Norimed Gmbh
- 12.8.1 Company Overview
- 12.8.2 Financial Overview
- 12.8.3 Services Offered
- 12.8.4 Key Developments
- 12.8.5 Swot Analysis
- 12.8.6 Key Strategies
- 12.9 Jsb Solutions Srl
- 12.9.1 Company Overview
- 12.9.2 Financial Overview
- 12.9.3 Services Offered
- 12.9.4 Key Developments
- 12.9.5 Key Strategies
- 12.10 Iqvia Holding, Inc
- 12.10.1 Company Overview
- 12.10.2 Financial Overview
- 12.10.3 Services Offered
- 12.10.4 Key Developments
- 12.10.5 Swot Analysis
- 12.10.6 Key Strategies
- 13 Data Citations
- List Of Tables
- Table 1 Qfd Modeling For Market Share Assessment
- Table 2 List Of Contract Research Organization By Europe/Europe Countries Offering Services To Pharmaceutical And Biopharmaceutical
- Table 3 Us And Europe Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 4 Us And Europe Pharma And Biotech Cro Market, For Clinical Development Services, By Country/Region, 2019–2032 (Usd Million)
- Table 5 Us And Europe Pharma And Biotech Cro Market, For Formulation Development Services, By Country/Region, 2019–2032 (Usd Million)
- Table 6 Us And Europe Pharma And Biotech Cro Market, For Pharmacovigilance Services, By Country/Region, 2019–2032 (Usd Million)
- Table 7 Us And Europe Pharma And Biotech Cro Market, For Laboratory Services, By Country/Region, 2019–2032 (Usd Million)
- Table 8 Us And Europe Pharma And Biotech Cro Market, For Consulting Services, By Country/Region, 2019–2032 (Usd Million)
- Table 9 Us And Europe Pharma And Biotech Cro Market, For Data Management Services, By Country/Region, 2019–2032 (Usd Million)
- Table 10 Us And Europe Pharma And Biotech Cro Market, For Others, By Country/Region, 2019–2032 (Usd Million)
- Table 11 Us And Europe Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 12 Us And Europe Pharma And Biotech Cro Market, For Phase I, By Country/Region, 2019–2032 (Usd Million)
- Table 13 Us And Europe Pharma And Biotech Cro Market, For Phase Ii, By Country/Region, 2019–2032 (Usd Million)
- Table 14 Us And Europe Pharma And Biotech Cro Market, For Phase Iii, By Country/Region, 2019–2032 (Usd Million)
- Table 15 Us And Europe Pharma And Biotech Cro Market, For Phase Iv, By Country/Region, 2019–2032 (Usd Million)
- Table 16 Us And Europe Pharma And Biotech Cro Market, For Post Marketing Studies (Pms), By Country/Region, 2019–2032 (Usd Million)
- Table 17 Us And Europe Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 18 Us And Europe Pharma And Biotech Cro Market, For Cardiovascular, By Country/Region, 2019–2032 (Usd Million)
- Table 19 Us And Europe Pharma And Biotech Cro Market, For Oncology, By Country/Region, 2019–2032 (Usd Million)
- Table 20 Us And Europe Pharma And Biotech Cro Market, For Dermatology, By Country/Region, 2019–2032 (Usd Million)
- Table 21 Us And Europe Pharma And Biotech Cro Market, For Gynaecology, By Country/Region, 2019–2032 (Usd Million)
- Table 22 Us And Europe Pharma And Biotech Cro Market, For Neurology, By Country/Region, 2019–2032 (Usd Million)
- Table 23 Us And Europe Pharma And Biotech Cro Market, For Respiratory Diseases, By Country/Region, 2019–2032 (Usd Million)
- Table 24 Us And Europe Pharma And Biotech Cro Market, For Orthopaedics, By Country/Region, 2019–2032 (Usd Million)
- Table 25 Us And Europe Pharma And Biotech Cro Market, For Ophthalmology, By Country/Region, 2019–2032 (Usd Million)
- Table 26 Us And Europe Pharma And Biotech Cro Market, For Others, By Country/Region, 2019–2032 (Usd Million)
- Table 27 Us And Europe Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 28 Us And Europe Pharma And Biotech Cro Market, For Pharmaceutical Companies, By Country/Region, 2019–2032 (Usd Million)
- Table 29 Us And Europe Pharma And Biotech Cro Market, For Biopharmaceutical Companies, By Country/Region, 2019–2032 (Usd Million)
- Table 30 Us & Europe Pharma And Biotech Cro Market, By Region, 2019–2032 (Usd Million)
- Table 31 Us: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 32 Us: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 33 Us: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 34 Us: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 35 Europe: Pharma And Biotech Cro Market, By Region, 2019–2032 (Usd Million)
- Table 36 Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 37 Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 38 Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 39 Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 40 Eastern Europe: Pharma And Biotech Cro Market, By Region, 2019–2032 (Usd Million)
- Table 41 Eastern Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 42 Eastern Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 43 Eastern Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 44 Eastern Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 45 Poland: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 46 Poland: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 47 Poland: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 48 Poland: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 49 Romania: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 50 Romania: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 51 Romania: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 52 Romania: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 53 Bulgaria: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 54 Bulgaria: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 55 Bulgaria: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 56 Bulgaria: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 57 Belarus: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 58 Belarus: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 59 Belarus: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 60 Belarus: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 61 Georgia: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 62 Georgia: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 63 Georgia: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 64 Georgia: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 65 Latvia: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 66 Latvia: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 67 Latvia: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 68 Latvia: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 69 Lithuania: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 70 Lithuania: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 71 Lithuania: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 72 Lithuania: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 73 Rest Of Eastern Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 74 Rest Of Eastern Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Billion)
- Table 75 Rest Of Eastern Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 76 Rest Of Eastern Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 77 Western Europe: Pharma And Biotech Cro Market, By Country, 2019–2032 (Usd Million)
- Table 78 Western Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 79 Western Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 80 Western Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 81 Western Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 82 Germany: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 83 Germany: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 84 Germany: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 85 Germany: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 86 France: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 87 France: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 88 France: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 89 France: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 90 Uk: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 91 Uk: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 92 Uk: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 93 Uk: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 94 Spain: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 95 Spain: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 96 Spain: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 97 Spain: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 98 Switzerland: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 99 Switzerland: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 100 Switzerland: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 101 Switzerland: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 102 Netherlands: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 103 Netherlands: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 104 Netherlands: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 105 Netherlands: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 106 Rest Of Western Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 107 Rest Of Western Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 108 Rest Of Western Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 109 Rest Of Western Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 110 Northern Europe: Pharma And Biotech Cro Market, By Country, 2019–2032 (Usd Million)
- Table 111 Northern Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 112 Northern Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 113 Northern Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 114 Northern Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 115 Denmark: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 116 Denmark: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 117 Denmark: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 118 Denmark: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 119 Sweden: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 120 Sweden: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 121 Sweden: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 122 Sweden: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 123 Norway: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 124 Norway: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 125 Norway: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 126 Norway: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 127 Iceland: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 128 Iceland: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 129 Iceland: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 130 Iceland: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 131 Finland: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 132 Finland: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 133 Finland: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 134 Finland: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 135 Ireland: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 136 Ireland: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 137 Ireland: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 138 Ireland: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 139 Rest Of Northern Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 140 Rest Of Northern Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 141 Rest Of Northern Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 142 Rest Of Northern Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 143 Southern Europe: Pharma And Biotech Cro Market, By Country, 2019–2032 (Usd Million)
- Table 144 Southern Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 145 Southern Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 146 Southern Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 147 Southern Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 148 Greece: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 149 Greece: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 150 Greece: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 151 Greece: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 152 Portugal: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 153 Portugal: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 154 Portugal: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 155 Portugal: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 156 Croatia: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 157 Croatia: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 158 Croatia: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 159 Croatia: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 160 Rest Of Southern Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 161 Rest Of Southern Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 162 Rest Of Southern Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 163 Rest Of Southern Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 164 Central Europe: Pharma And Biotech Cro Market, By Country, 2019–2032 (Usd Million)
- Table 165 Central Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 166 Central Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 167 Central Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 168 Central Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 169 Hungary: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 170 Hungary: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 171 Hungary: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 172 Hungary: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 173 Slovakia: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 174 Slovakia: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 175 Slovakia: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 176 Slovakia: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 177 Czech Republic: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 178 Czech Republic: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 179 Czech Republic: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 180 Czech Republic: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 181 Austria: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 182 Austria: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 183 Austria: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 184 Austria: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 185 Rest Of Central Europe: Pharma And Biotech Cro Market, By Service Type, 2019–2032 (Usd Million)
- Table 186 Rest Of Central Europe: Pharma And Biotech Cro Market, By Phase, 2019–2032 (Usd Million)
- Table 187 Rest Of Central Europe: Pharma And Biotech Cro Market, By Indication, 2019–2032 (Usd Million)
- Table 188 Rest Of Central Europe: Pharma And Biotech Cro Market, By End User, 2019–2032 (Usd Million)
- Table 189 Aquisition
- Table 190 Facility Launch
- Table 191 Investment
- Table 192 Expansion
- Table 193 Klifo: Services Offered
- Table 194 Klifo: Key Developments
- Table 195 Optimapharm: Services Offered
- Table 196 Optimapharm: Key Developments
- Table 197 Fgk Clinical Research: Services Offered
- Table 198 Fgk Clinical Research: Key Developments
- Table 199 Ergomed Group: Services Offered
- Table 200 Ergomed Group: Key Developments
- Table 201 Astrum/Pharmlog: Services Offered
- Table 202 Astrum/Pharmlog: Services Offered
- Table 203 Kapadi: Services Offered
- Table 204 Tfs Healthscience: Services Offered
- Table 205 Winicker Norimed Gmbh: Services Offered
- Table 206 Jsb Solutions Srl: Service Offered
- Table 207 Iqvia Holding, Inc: Services Offered
- List Of Figures
- Figure 1 Us And Europe Pharma And Biotech Cro Market: Structure
- Figure 2 Us & Europe Pharma And Biotech Cro Market: Market Growth Factor Analysis (2023-2032)
- Figure 3 Driver Impact Analysis (2019-2032)
- Figure 4 Restraint Impact Analysis (2029-2032)
- Figure 5 Porter's Five Forces Analysis: Us & Europe Pharma And Biotech Cro Market
- Figure 6 Us And Europe Pharma And Biotech Cro Market, Service Type, 2023 & 2032 (Usd Million)
- Figure 7 Us And Europe Pharma And Biotech Cro Market, By Service Type, 2023 & 2032 (Usd Million)
- Figure 8 Us And Europe Pharma And Biotech Cro Market Share (%), By Service Type, 2023
- Figure 9 Us And Europe Pharma And Biotech Cro Market, Phase, 2023 & 2032 (Usd Million)
- Figure 10 Us And Europe Pharma And Biotech Cro Market, By Phase, 2023 & 2032 (Usd Million)
- Figure 11 Us And Europe Pharma And Biotech Cro Market Share (%), By Phase, 2023
- Figure 12 Us And Europe Pharma And Biotech Cro Market, Indication, 2023 & 2032 (Usd Million)
- Figure 13 Us And Europe Pharma And Biotech Cro Market, By Indication, 2023 & 2032 (Usd Million)
- Figure 14 Us And Europe Pharma And Biotech Cro Market Share (%), By Indication, 2023
- Figure 15 Us And Europe Pharma And Biotech Cro Market, End User, 2023 & 2032 (Usd Million)
- Figure 16 Us And Europe Pharma And Biotech Cro Market, By End User, 2023 & 2032 (Usd Million)
- Figure 17 Us And Europe Pharma And Biotech Cro Market Share (%), By End User, 2023
- Figure 18 Us & Europe Pharma And Biotech Cro Market, By Region, 2023 & 2032 (Usd Million)
- Figure 19 Us & Europe Pharma And Biotech Cro Market Share, By Region, 2023 (% Share)
- Figure 20 Us Market Analysis: Pharma And Biotech Cro Market, 2019-2032 (Usd Million)
- Figure 21 Europe Market Analysis: Pharma And Biotech Cro Market, 2019-2032 (Usd Million)
- Figure 22 Europe Pharma And Biotech Cro Market Share, By Region, 2023 & 2032 (Usd Million)
- Figure 23 Europe Pharma And Biotech Cro Market Share, By Region, 2023 (%)
- Figure 24 Eastern Europe Pharma And Biotech Cro Market Share, By Country, 2023 & 2032 (Usd Million)
- Figure 25 Eastern Europe Pharma And Biotech Cro Market Share, By Region, 2023 (%)
- Figure 26 Western Europe: Pharma And Biotech Cro Market Share, By Country, 2023 & 2032 (Usd Million)
- Figure 27 Western Europe: Pharma And Biotech Cro Market Share, By Country, 2023 (%)
- Figure 28 Northern Europe: Pharma And Biotech Cro Market Share, By Country, 2023 & 2032 (Usd Million)
- Figure 29 Northern Europe: Pharma And Biotech Cro Market Share, By Country, 2023 (%)
- Figure 30 Southern Europe: Pharma And Biotech Cro Market Share, By Country, 2023 & 2032 (Usd Million)
- Figure 31 Southern Europe: Pharma And Biotech Cro Market Share, By Country, 2023 (%)
- Figure 32 Central Europe: Pharma And Biotech Cro Market Share, By Country, 2023 & 2032 (Usd Million)
- Figure 33 Central Europe: Pharma And Biotech Cro Market Share, By Country, 2023 (%)
- Figure 34 Us And Europe Pharma And Biotech Cro Market Players: Competitive Analysis, 2023
- Figure 35 Competitor Dashboard: Us And Europe Pharma And Biotech Cro Market
- Figure 36 Optimapharm: Swot Analysis
- Figure 37 Ergomed Group: Swot Analysis
- Figure 38 Kapadi: Swot Analysis
- Figure 39 Winicker Norimed Gmbh: Swot Analysis
- Figure 40 Iqvia Holding, Inc: Swot Analysis
- Figure 41 Iqvia Holding, Inc: Swot Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook